A US cystic fibrosis pulmonologist shares perspectives on CF diagnosis and genetics, real-world use and switching considerations for CFTR modulators, the outlook for emerging therapies (including gene-based approaches), and practical access and reimbursement themes.

This interview was conducted on December 11, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.